Shanghai Yizhong Pharmaceutical Co., Ltd. (SHA:688091)
China · Delayed Price · Currency is CNY 59.15
+0.84 (1.44%)
Apr 8, 2026, 3:00 PM CST
SHA:688091 Market Cap
SHA:688091 has a market cap or net worth of 12.15 billion as of April 8, 2026. Its market cap has increased by 37.40% in one year.
Market Cap
12.15B
Enterprise Value
11.67B
Revenue
317.08M
Ranking
n/a
PE Ratio
190.81
Stock Price
59.15
Market Cap Chart
Since September 9, 2021, SHA:688091's market cap has increased from 5.18B to 12.15B, an increase of 134.44%. That is a compound annual growth rate of 20.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 8, 2026 | 12.15B | 25.85% |
| Dec 31, 2025 | 9.66B | 17.68% |
| Dec 31, 2024 | 8.20B | -19.01% |
| Dec 29, 2023 | 10.13B | 0.86% |
| Dec 30, 2022 | 10.04B | 111.52% |
| Dec 31, 2021 | 4.75B | -8.39% |
| Sep 9, 2021 | 5.18B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zhejiang Jingxin Pharmaceutical | 13.36B |
| Shenzhen Chipscreen Biosciences | 13.30B |
| Henan Lingrui Pharmaceutical | 12.38B |
| Zhejiang Hisun Pharmaceutical | 12.25B |
| Yantai Dongcheng Pharmaceutical Group | 12.02B |
| Porton Pharma Solutions | 11.64B |
| Guangdong Taienkang Pharmaceutical | 11.30B |
| Zhejiang CONBA Pharmaceutical | 11.16B |